Brun Scott C. — SEC Form 4 filings
SEC reporting owner CIK 1863614. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-27.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-04 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | Director | 4 | — | — | 9 |
| Forte Biosciences, Inc. (FBRX) | Director | 4 | — | — | 8 |
| Jasper Therapeutics, Inc. (JSPR) | Director | 2 | — | — | 2 |
Form 4 filings — Brun Scott C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | Forte Biosciences, Inc. (FBRX) | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative) | EDGAR |
| 2026-06-10 | 4 | Cabaletta Bio, Inc. (CABA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Cabaletta Bio, Inc. (CABA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Cabaletta Bio, Inc. (CABA) | Disposition to issuer (D): 44,000 (derivative) @ $0 · Grant/award (A): 44,000 (derivative) @ $0 · Disposition to issuer (D): 22,000 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 · Disposition to issuer (D): 22,000 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Cabaletta Bio, Inc. (CABA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1863614 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →